- idUS
- Listar por autor
Listar por autor "Schenker, Michael"
Mostrando ítems 1-1 de 1
-
Artículo
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
Weber, Jeffrey S.; Schadendorf, Dirk; Del Vecchio, Michele; Larkin, James; Atkinson, Victoria; Schenker, Michael; Cruz Merino, Luis de la; Long, Georgina V. (American Society of Clinical Oncology, 2023)PURPOSE Ipilimumab and nivolumab have each shown treatment benefit for high-risk resected melanoma. The phase III CheckMate ...